CIK 0001739104
- Large accelerated filer
Elanco Animal Health Inc
Sign in to watch- Ticker
- ELAN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 825497352
- Phone
- +1 877-352-6261
- Business address
- 450 ELANCO CIRCLE, INDIANAPOLIS, IN, 46221
- Open-market buys, last 90 days
- $935,920
- in 1 filing
- Open-market sales, last 90 days
- $100,050
- in 1 filing, $100K under 10b5-1 plans
Net +$835,870. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-01 | Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR | Grant or award · Employee Stock Option(right to buy) | +234,160 | 234,160 | ||
| 2022-03-01 | Kinard David S SEE REMARKS | Grant or award | +8,665 | 97,241 | ||
| 2022-03-01 | Kinard David S SEE REMARKS | Shares withheld for taxes | −1,724 | $28.94 | $50K | 95,517 |
| 2022-03-01 | Kinard David S SEE REMARKS | Grant or award · Employee Stock Option(right to buy) | +23,026 | 23,026 | ||
| 2022-03-01 | Kirberger Marcela A. SEE REMARKS | Grant or award | +10,583 | 19,155 | ||
| 2022-03-01 | Kirberger Marcela A. SEE REMARKS | Grant or award · Employee Stock Option(right to buy) | +28,123 | 28,123 | ||
| 2022-03-01 | Urbanek David Alan SEE REMARKS | Grant or award | +10,341 | 95,119 | ||
| 2022-03-01 | Urbanek David Alan SEE REMARKS | Shares withheld for taxes | −1,800 | $28.94 | $52K | 93,319 |
| 2022-03-01 | Urbanek David Alan SEE REMARKS | Grant or award · Employee Stock Option(right to buy) | +27,480 | 27,480 | ||
| 2022-03-01 | de Brabander Ellen SEE REMARKS | Grant or award | +14,496 | 60,131 | ||
| 2022-03-01 | de Brabander Ellen SEE REMARKS | Grant or award · Employee Stock Option(right to buy) | +38,522 | 38,522 | ||
| 2022-03-01 | Anand Kapila K Director | Purchase | +1,000 | $28.48 | $28K | 27,467 |
| 2022-03-01 | HOOVER R DAVID Director | Purchase | +5,000 | $28.66 | $143K | 110,000 |
| 2022-02-28 | HOOVER R DAVID Director | Grant or award · Deferred Stock Units | +375.45 | $28.41 | $11K | 20,395.34 |
| 2022-02-28 | Kurzius Lawrence Erik Director | Grant or award · Deferred Stock Units | +322.66 | $28.41 | $9K | 9,692.97 |
| 2022-02-28 | BILBREY JOHN P Director | Grant or award · Deferred Stock Units | +310.92 | $28.41 | $9K | 9,166.54 |
| 2022-02-22 | Meer James M CHIEF ACCOUNTING OFFICER | Grant or award | +3,683 | 18,290 | ||
| 2022-02-22 | Meer James M CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −1,263 | $25.98 | $33K | 17,027 |
| 2022-02-22 | Cabral Ramiro Martin See Remarks | Grant or award | +32,339 | 86,716 | ||
| 2022-02-22 | Cabral Ramiro Martin See Remarks | Shares withheld for taxes | −13,331 | $25.98 | $346K | 73,385 |
Page 31 of 35 · 697 trades